查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411304

临床试验用品市场：2024-2030 年按阶段、类型、产品、治疗领域和最终用户分類的全球预测

Clinical Trial Supplies Market by Phase (Phase 1, Phase 2, Phase 3), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年临床试验用品市场规模为33.5亿美元，预计2024年将达36.4亿美元，2030年将达到59.2亿美元，复合年增长率为8.43%。

全球临床试验用品市场

主要市场统计
基准年[2023] 33.5亿美元
预测年份 [2024] 36.4亿美元
预测年份 [2030] 59.2亿美元
复合年增长率（%） 8.43%
临床试验用品市场-IMG1

临床试验用品是临床研究的基本且复杂的组成部分，最终有助于为成功的治疗方法突破和患者治疗途径的突破性改进铺平道路。这些药物支持从临床前测试到上市后监测的各个研究阶段，促进临床试验的无缝管理和进行。全球感染疾病和慢性病的流行以及随之而来的製药和生物製药行业的临床试验和研发费用的增加将刺激市场成长。与临床试验供应相关的高成本、严格的供应法规以及跨境物流挑战限制了市场成长。专注于药物开发和转向以患者为中心的临床试验可以改善临床试验患者招募、试验入组和参与者保留率。各种临床试验用品的进步预计也将为製药和生物製药公司开闢新的研究途径。

区域洞察

以美国和加拿大为中心的美洲地区慢性病诊断率高，医疗基础设施强大，对临床试验供应高度依赖。去年註册的主要专利与优化供应链模型和采用先进分析来匹配测试供应与需求有关。由于医疗保健的取得和支出存在差异，欧盟 (EU)、中东和非洲的需求多种多样。在欧洲，受研发重点投资和老年人口快速成长的推动，对临床试验用品的需求稳定。相较之下，中东和非洲国家是新兴市场，研究活动活跃但由于资金和基础设施有限而进展缓慢。包括中国、日本和印度在内的亚太地区由于医疗基础设施的大量投资，疾病发生率很高。蓬勃发展的製药业正在推动这些地区的临床试验用品市场，其需求是由成本效益而不是速度驱动的。

FPNV定位矩阵

FPNV定位矩阵对于评估临床试验用品市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对临床试验用品市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-临床试验用品市场的市场规模与预测是多少？

2-在临床试验用品市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-临床试验用品市场的技术趋势和法律规范是什么？

4-临床试验用品市场主要供应商的市场占有率为何？

5-进入临床试验用品市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 製药和生物製药产业研发支出增加
    • 抑制因素
      • 临床试验耗材成本高
    • 机会
      • 重视药物开发并转向以病人为中心的临床试验
      • 多样化临床试验用品的持续进步
    • 任务
      • 临床试验用品严格监管
  • 市场区隔分析
    • 阶段：对临床试验用品的需求随着每个阶段的增加而增加，以便做出有关临床试验的最佳决策
    • 类型：慢性病治疗方法突破导致生物製药需求激增
    • 产品：辅助药物是临床试验的重要组成部分，因为它们对于确保研究的安全性和整体效率具有重要意义。
    • 治疗领域：世界各地日益增加的感染疾病负担正在创造对临床试验用品的需求
    • 最终用户：由于研发活动外包的增加，CRO 中临床试验用品的使用增加
  • 市场趋势分析
    • 老牌製药公司专注于增加临床试验数量，以及美洲对临床试验用品不断增长的需求
    • 扩大政府支持法规和标准的力度，并加强亚太地区的临床试验能力
    • 欧洲、中东和非洲地区临床试验数量不断增加，製药业强大且先进
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 临床试验用品市场分阶段状况

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第七章 临床试验用品市场：依类型

  • 生物製药
  • 医疗设备
  • 低分子

第八章临床试验用品市场：副产品

  • 补充药物
  • 互动式回应技术 (IRT) 解决方案
  • 实验室用品
    • 离心机
    • 显微镜
    • 吸管
    • 试剂
  • 医疗设备和诊断
  • 药局用品
    • 生物危害袋
    • 复合式无菌隔离器
    • 消毒器
  • 调查数据
  • 安全装置

第九章依治疗领域分類的临床试验用品市场

  • 心臟病学
  • 遗传疾病
  • 免疫学
  • 感染疾病
  • 代谢紊乱
  • 神经病学
  • 肿瘤学

第十章临床试验用品市场：依最终使用者分类

  • 合约研究组织
  • 製药和生物技术公司

第十一章 北美和南美临床试验用品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太临床试验用品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东、非洲临床试验用品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 併购
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强
    • 投资、资金筹措
    • 奖项/奖励/扩展

第15章竞争组合

  • 主要公司简介
    • 3M Company
    • Abbott Laboratories
    • Almac Group Limited
    • B. Braun SE
    • Baxter International, Inc.
    • Bayer AG
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Cardinal Health, Inc.
    • Charles River Laboratories, Inc.
    • COREX LOGISTICS LIMITED
    • Emsere BV by Medicapital Holdco BV
    • Eppendorf SE
    • Evident Corporation by Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Fujifilm Group
    • Hipro Biotechnology Co., Ltd.
    • Hitachi, Ltd.
    • HORIBA, Ltd.
    • ICON PLC
    • Immudex ApS
    • Incyte Corporation
    • IQVIA Inc.
    • Johnson & Johnson Services, Inc.
    • KLIFO A/S
    • Labnet International
    • Leica Microsystems GmbH by Danaher Corporation
    • llumina, Inc.
    • Lonza Group Ltd.
    • Medline Industries, LP
    • Merck KGaA
    • Myonex, LLC
    • Novo Nordisk A/S
    • Nuvisan GmbH
    • Parexel International Corporation
    • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • PerkinElmer Inc. by Revvity, Inc.
    • Pfizer Inc.
    • Promega Corporation
    • Recipharm AB
    • Rubicon Research Pvt. Ltd.
    • Sekisui Diagnostics Group
    • Sharp Services, LLC
    • Siemens Healthcare GmbH
    • Smith & Nephew PLC
    • Stryker Corporation
    • Thermo Fisher Scientific Inc.
    • Woodley Equipment Company Ltd.
  • 主要产品系列

第十六章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-E0619F076722

[187 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Global Clinical Trial Supplies Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%
Clinical Trial Supplies Market - IMG1

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supplies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Type Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supplies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supplies Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supplies Market?

4. What is the market share of the leading vendors in the Clinical Trial Supplies Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supplies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Clinical Trial Supplies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
    • 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
    • 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
    • 8.5.1. Centrifuges
    • 8.5.2. Microscopes
    • 8.5.3. Pipettes
    • 8.5.4. Reagents
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
    • 8.7.1. Biohazard Bags
    • 8.7.2. Compounding Aseptic Isolators
    • 8.7.3. Sterilization Equipment
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
      • 14.3.1.2. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
      • 14.3.1.3. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
      • 14.3.2.2. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
      • 14.3.2.3. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
      • 14.3.2.4. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.3. New Product Launch & Enhancement
      • 14.3.3.1. Thermo Fisher Scientific Launches New Smart Refrigerator Series
      • 14.3.3.2. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.4. Investment & Funding
      • 14.3.4.1. Experic Closes USD 14 Million Series B Financing
      • 14.3.4.2. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
    • 14.3.5. Award, Recognition, & Expansion
      • 14.3.5.1. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. 3M Company
    • 15.1.2. Abbott Laboratories
    • 15.1.3. Almac Group Limited
    • 15.1.4. B. Braun SE
    • 15.1.5. Baxter International, Inc.
    • 15.1.6. Bayer AG
    • 15.1.7. Becton, Dickinson and Company
    • 15.1.8. Bio-Rad Laboratories, Inc.
    • 15.1.9. Bruker Corporation
    • 15.1.10. Cardinal Health, Inc.
    • 15.1.11. Charles River Laboratories, Inc.
    • 15.1.12. COREX LOGISTICS LIMITED
    • 15.1.13. Emsere B.V by Medicapital Holdco B.V.
    • 15.1.14. Eppendorf SE
    • 15.1.15. Evident Corporation by Olympus Corporation
    • 15.1.16. F. Hoffmann-La Roche Ltd.
    • 15.1.17. Fujifilm Group
    • 15.1.18. Hipro Biotechnology Co., Ltd.
    • 15.1.19. Hitachi, Ltd.
    • 15.1.20. HORIBA, Ltd.
    • 15.1.21. ICON PLC
    • 15.1.22. Immudex ApS
    • 15.1.23. Incyte Corporation
    • 15.1.24. IQVIA Inc.
    • 15.1.25. Johnson & Johnson Services, Inc.
    • 15.1.26. KLIFO A/S
    • 15.1.27. Labnet International
    • 15.1.28. Leica Microsystems GmbH by Danaher Corporation
    • 15.1.29. llumina, Inc.
    • 15.1.30. Lonza Group Ltd.
    • 15.1.31. Medline Industries, LP
    • 15.1.32. Merck KGaA
    • 15.1.33. Myonex, LLC
    • 15.1.34. Novo Nordisk A/S
    • 15.1.35. Nuvisan GmbH
    • 15.1.36. Parexel International Corporation
    • 15.1.37. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
    • 15.1.38. PerkinElmer Inc. by Revvity, Inc.
    • 15.1.39. Pfizer Inc.
    • 15.1.40. Promega Corporation
    • 15.1.41. Recipharm AB
    • 15.1.42. Rubicon Research Pvt. Ltd.
    • 15.1.43. Sekisui Diagnostics Group
    • 15.1.44. Sharp Services, LLC
    • 15.1.45. Siemens Healthcare GmbH
    • 15.1.46. Smith & Nephew PLC
    • 15.1.47. Stryker Corporation
    • 15.1.48. Thermo Fisher Scientific Inc.
    • 15.1.49. Woodley Equipment Company Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • FIGURE 4. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • FIGURE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2019-2023
  • TABLE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 17. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 18. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 19. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 20. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 21. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 22. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 23. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 24. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 25. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 26. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 27. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 28. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 29. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 30. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 31. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 32. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 33. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 34. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 35. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 36. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 37. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 38. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 39. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 40. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 41. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2030 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 65. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 71. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 72. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2019-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 101. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 102. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 108. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 109. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 115. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 116. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 122. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 123. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 130. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 144. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 157. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 158. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 164. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 165. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 171. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 172. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
  • TABLE 186. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 187. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 193. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 194. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 200. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 201. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 207. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 208. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 214. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 215. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 221. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 222. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 228. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 229. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 242. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 243. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 249. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 250. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 256. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 257. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 263. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 264. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 270. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 271. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 291. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 292. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 298. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 299. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 312. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 313. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2019-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
  • TABLE 333. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 334. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 335. CLINICAL TRIAL SUPPLIES MARKET LICENSE & PRICING